7Baggers
 Europe Not A Priority For MSD/Verona COPD Drug Ohtuvayre  Citeline News & Insights Mon, 17 Nov 2025 17:36:59 GMT
 Is Verona Pharma plc Depositary Receipt stock ready for a breakout  newser.com Thu, 13 Nov 2025 18:09:32 GMT
 published on: 2025-11-07 03:08:10  newser.com Fri, 07 Nov 2025 09:08:10 GMT
 published on: 2025-11-06 05:35:57  newser.com Thu, 06 Nov 2025 11:35:57 GMT
 published on: 2025-11-06 05:11:23  newser.com Thu, 06 Nov 2025 11:11:23 GMT
 published on: 2025-11-06 05:11:23  newser.com Wed, 05 Nov 2025 06:27:53 GMT
 published on: 2025-11-05 00:27:53  newser.com Wed, 05 Nov 2025 06:27:53 GMT
 published on: 2025-11-02 22:47:11  newser.com Mon, 03 Nov 2025 03:47:11 GMT
 published on: 2025-11-02 11:45:51  newser.com Sun, 02 Nov 2025 16:45:51 GMT
 published on: 2025-11-02 11:35:24  newser.com Sun, 02 Nov 2025 16:35:24 GMT
 msd still seeking deals 'with urgency' after verona takeover  pharmaphorum Fri, 31 Oct 2025 11:08:22 GMT

Verona Pharma plc
(NASDAQ:VRNA) 

VRNA stock logo

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 ...

Founded: 2005
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends